The apoAI-CIII-AIV gene cluster

M Groenendijk, RM Cantor, TWA de Bruin… - Atherosclerosis, 2001 - Elsevier
The relationship between variations in the apoAI-CIII-AIV gene cluster and plasma lipid traits
has been recognized for at least 15 years. Most studies have been focused upon the …

Apo A-IV: an update on regulation and physiologic functions

S Stan, E Delvin, M Lambert, E Seidman… - Biochimica et Biophysica …, 2003 - Elsevier
Apolipoprotein (apo) A-IV, first identified 28 years ago as a plasma lipoprotein moiety, is now
known to participate in the regulation of various metabolic pathways. It is synthesized …

Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease

F Kronenberg, M Stühlinger, E Trenkwalder… - Journal of the American …, 2000 - jacc.org
OBJECTIVES The objective of this study was to evaluate the relation between
apolipoprotein A-IV (apoA-IV) plasma concentrations and coronary artery disease (CAD) …

Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas …

G Siest, S Visvikis, B Herbeth, R Gueguen… - 1998 - degruyter.com
The main objective of the Stanislas cohort is to study the role and the contribution of genetic
and environmental factors to cardiovascular status. We plan: a) to describe the degree of …

Gene-diet interaction in determining plasma lipid response to dietary intervention

JM Ordovas, J Lopez-Miranda, P Mata… - Atherosclerosis, 1995 - Elsevier
It has long been known that there is an extremely high degree of variability in both human
and nonhuman primates in terms of low density lipoprotein cholesterol (LDL-C) lowering in …

Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels

WR Wong, E Hawe, LK Li, GJ Miller, V Nicaud… - Circulation …, 2003 - Am Heart Assoc
The impact of common variants in the apolipoprotein gene cluster (APOC3-A4-A5) on
prospective coronary heart disease (CHD) risk was examined in healthy UK men. Of the …

The genetics of serum lipid responsiveness to dietary interventions

JM Ordovas - Proceedings of the Nutrition Society, 1999 - cambridge.org
CHD is a multifactorial disease that is associated with non-modifiable risk factors, such as
age, gender and genetic background, and with modifiable risk factors, including elevated …

Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation

WMR Wong, AB Gerry, W Putt, JL Roberts… - Atherosclerosis, 2007 - Elsevier
Apolipoprotein A-IV (apoA-IV) inhibits lipid peroxidation, thus demonstrating potential anti-
atherogenic properties. The aim of this study was to investigate how the inhibition of low …

Apolipoprotein A-IV polymorphisms and diet-gene interactions

RB Weinberg - Current opinion in lipidology, 2002 - journals.lww.com
Apolipoprotein A-IV is a 46 kDa glycoprotein that is synthesized by intestinal enterocytes
and is incorporated into the surface of nascent chylomicrons. Considerable evidence …

Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II

RM Fisher, H Burke, V Nicaud, C Ehnholm… - Journal of lipid …, 1999 - ASBMB
The aims of the study were to investigate associations of the apolipoprotein (apo) A-IV
polymorphisms Thr347Ser and Gln360His with anthropomorphic measurements and fasting …